Molecular hydrogen has also been used to improve pulmonary hypertension (PAH) in a rat model by suppressing macrophage accumulation, reducing oxidative stress, and modulating the STAT3/NFAT axis, the latter which are important transcription factors associated with the immune response (21). The gene discussed is STAT3; the disease is pulmonary arterial hypertension.